The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United StatesLynn Malec, Margaret V. Ragni, Robert F. Sidonio et al.|American Journal of Hematology|2020Cited by 31
Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor ConcentratesLynn Malec, Margaret V. Ragni, Dunlei Cheng et al.|Blood|2018Cited by 2
Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United StatesLynn Malec, Margaret V. Ragni, Char Witmer et al.|Blood|2018Cited by 2